EMvision Medical Devices Ltd
ASX:EMV
Balance Sheet
Balance Sheet Decomposition
EMvision Medical Devices Ltd
EMvision Medical Devices Ltd
Balance Sheet
EMvision Medical Devices Ltd
| Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
4
|
5
|
10
|
7
|
10
|
19
|
10
|
|
| Cash |
1
|
4
|
5
|
10
|
7
|
10
|
19
|
10
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
5
|
6
|
10
|
7
|
10
|
22
|
14
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
2
N/A
|
5
+214%
|
6
+19%
|
11
+79%
|
9
-21%
|
12
+35%
|
24
+108%
|
16
-35%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
1
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
1
|
6
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
2
|
3
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+37%
|
0
+6%
|
1
+47%
|
1
+98%
|
6
+349%
|
5
-15%
|
6
+15%
|
|
| Equity | |||||||||
| Common Stock |
2
|
8
|
12
|
21
|
23
|
26
|
42
|
42
|
|
| Retained Earnings |
1
|
3
|
6
|
11
|
16
|
21
|
23
|
32
|
|
| Total Equity |
1
N/A
|
5
+260%
|
6
+20%
|
10
+82%
|
7
-30%
|
5
-28%
|
19
+262%
|
9
-50%
|
|
| Total Liabilities & Equity |
2
N/A
|
5
+214%
|
6
+19%
|
11
+79%
|
9
-21%
|
12
+35%
|
24
+108%
|
16
-35%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
58
|
58
|
64
|
72
|
78
|
78
|
85
|
86
|
|